WallStreetZenWallStreetZen

NYSEMKT: TOVX
Theriva Biologics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

TOVX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$18.3M
Current Profit Margin
0%

TOVX Return on Equity

Current Company
-42.9%
Current Industry
-63.5%
Current Market
188%
TOVX's Return on Equity (-42.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TOVX announces earnings.

TOVX Return on Assets

Current Company
-29.3%
Current Industry
2.9%
TOVX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TOVX Return on Capital Employed

Current Company
-41.23%
Current Industry
19.5%
TOVX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TOVX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TOVX$0.00-$19.47M-$18.35MN/AN/A
KA$5.44M-$13.01M-$14.10M+13.89%N/A
ADIL$0.00-$5.12M-$5.12MN/AN/A
TENX$0.00-$7.68M-$7.71MN/AN/A
HEPA$0.00-$49.26M-$48.93MN/AN/A
View Top Biotech Stocks

TOVX earnings dates

Next earnings date
May 9, 2024

Theriva Biologics Earnings & Revenue FAQ

What were TOVX's earnings last quarter?

On Invalid Date, Theriva Biologics (NYSEMKT: TOVX) reported Q4 2023 earnings per share (EPS) of -$0.33, up 25% year over year. Total Theriva Biologics earnings for the quarter were -$5.49 million. In the same quarter last year, Theriva Biologics's earnings per share (EPS) was -$0.44.

If you're new to stock investing, here's how to buy Theriva Biologics stock.

What was TOVX's earnings growth in the past year?

As of Q2 2024, Theriva Biologics's earnings has grown year over year. Theriva Biologics's earnings in the past year totalled -$18.35 million.

What is TOVX's earnings date?

Theriva Biologics's earnings date is Invalid Date. Add TOVX to your watchlist to be reminded of TOVX's next earnings announcement.

What was TOVX's revenue last quarter?

On Invalid Date, Theriva Biologics (NYSEMKT: TOVX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Theriva Biologics's revenue was $0.00.

What was TOVX's revenue growth in the past year?

As of Q2 2024, Theriva Biologics's revenue has grown null year over year. Theriva Biologics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.